The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 17

More JCP Articles

JCP
Emerging Approaches in Schizophrenia
Educational Activity

September 26, 2024

This collection from Psychiatrist.com News highlights the latest developments in schizophrenia treatment, emphasizing new therapies that go beyond traditional dopaminergic approaches. Clinicians will gain insights into managing symptoms, cognitive…
JCP
Regression: Understanding What Covariates and Confounds Do in Adjusted Analyses
Clinical and Practical Psychopharmacology

September 18, 2024

Basic terms and concepts of regression analysis are presented, as well as three useful examples that involve readers in learning how regressions work.
JCP
Diagnostic Assessment via Telehealth vs Face-to-Face
Systematic Review

September 16, 2024

Several small studies suggest that telehealth holds promise for psychiatric assessments, especially when in-person evaluations are not feasible.
, , , et al
JCP
Medication Use and Lines of Treatment in Patients With Insomnia Disorder
Original Research

September 11, 2024

In this Canadian study, the annual cost of medications for insomnia was $54.8 million, and $30.3 million (55.2%) met inappropriate medication use criteria.
, , , et al
JCP
Bridge Symptoms Between Borderline Personality and PTSD
Original Research

September 9, 2024

Self-aggression, feelings of emptiness, dissociation, and feelings of detachment were found to be bridge symptoms between borderline personality disorder and PTSD. Targeting these might allow better prevention and management…
, , , et al
JCP
Collaborative vs Specialty Care for Depression or Anxiety
Original Research

September 4, 2024

Model effects at 6 months revealed that patients assigned to collaborative care showed significantly greater improvement than those assigned to specialty psychiatry.
, , , et al
JCP
Baseline Cognition Is Not Associated With Depression Outcomes in Vortioxetine
Original Research

September 4, 2024

This study suggests that cognitive function does not moderate depression outcomes in vortioxetine, with results comparable to other antidepressants.
, , , et al
JCP
Perinatal Timing of OCD Onset
Original Research

August 28, 2024

Findings show that OCD is most likely to begin in the early postpartum, with a rapid transition from symptoms to disorder. People with pre-existing OCD are vulnerable to symptom…
, ,
JCP
SSRI Discontinuation and AUD Relapse
Case Report

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to…
, , , et al
JCP
Reproductive Pharmacovigilance and Best Practices
Commentary

August 26, 2024

Dr Freeman discusses a recent study by Pacilio et al that characterized real world practices around ketamine treatment and pregnancy testing, consent processes, and contraception use. She emphasizes the…
JCP
Safe Ketamine Use and Pregnancy: A Nationwide Survey
Original Research

August 26, 2024

Risks of fetal ketamine exposure are often overlooked, indicating a need for awareness about reproductive concerns when prescribing ketamine for psychiatric disorders.
, , , et al
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
Clinical and Practical Psychopharmacology

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe